Skip to main content
. 2020 Sep 15;12(9):5789–5796.

Figure 1.

Figure 1

Upregulation of miRNA-543 in gastric carcinoma. A. MiRNA-543 level in gastric carcinoma tissues and adjacent normal tissues. B. MiRNA-543 level in gastric carcinoma patients with stage I+II and stage III+IV. C. MiRNA-543 level in gastric carcinoma patients with negative or positive metastasis. D. MiRNA-543 level in gastric carcinoma cells and gastric mucosal cells.